Biodelphis Therapeutics raises CHF 100,000

Biodelphis Therapeutics, an EPFL spin-off, couples a small molecule with an antibody to treat osteoporosis without acting on the whole body. The CHF 100,000 Tech Seed loan from FIT funds the studies that precede the first human trials.

Announced on
Round
Loan
Amount
CHF 100,000
Location
Lausanne, canton of Vaud
Sector
Biotech & life sciences

Investors

Preparing a similar round?

The diagnostic shows you the instruments and investors that fit your stage.

Start the diagnostic